Clinical Trials Browser

OTHER × dostarlimab × Head & Neck × Clear all

NCT05784012 2026-06-04

RADIAN

Phase 1/2 Active not recruiting

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Laryngeal Diseases, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT04313504 2026-05-07

Study Evaluating the Efficacy of Niraparib and Dostarlimab (TSR-042) in Recurrent/Metastatic HNSCC

Phase 2 Completed

10 enrolled 9 charts

Head and Neck Neoplasms

NCT07408063 2026-04-29

BeeHive

Phase 2 Recruiting

Squamous Cell Carcinoma of Head and Neck

NCT04779151 2025-12-01

NIRADO

Phase 2 Terminated

GastrointestinalGenitourinaryHead & Neck

Biliary Tract Neoplasms, Carcinoma, Renal Cell, Head and Neck Neoplasms

NCT04681469 2022-08-04

PRIME

Phase 2 Recruiting

Squamous Cell Carcinoma of Head and Neck